High-dose simvastatin for aneurysmal subarachnoid hemorrhage: Multicenter randomized controlled double-blinded clinical trial

Stroke

Volumn 46, Issue 2, 2015, Pages 382-388

  Wong, George K C ^a   Chan, David Y C ^a   Siu, Deyond Y W ^b   Zee, Benny C Y ^c   Poon, Wai S ^a   Chan, Matthew T V ^a   Gin, Tony ^a   Leung, Michael ^c   Zhu, X L ^a   Liang, M ^d   Tan, H B ^e   Lee, M W ^f   Wong, C K ^f   Chan, T K ^g   Po, Y C ^g   Woo, P Y ^b   Chan, K Y ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b KWONG WAH HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d GUANGXI MEDICAL UNIVERSITY   (China)

^e Sichuan Province People's Hospital   (China)

^f PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

^g PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

simvastatin; stroke; subarachnoid hemorrhage

Indexed keywords

SIMVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DELAYED ISCHEMIC DEFICIT; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEALTH CENTER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM; AGED; CLINICAL TRIAL; FOLLOW UP; MIDDLE AGED;

ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; SIMVASTATIN; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 84922277579     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007006     Document Type: Article

References (30)

1. Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: population-based study and systematic review. Neurology. 2010;74:1494-1501. doi: 10.1212/WNL.0b013e3181dd42b3.
2. Wong GK, Ng RY, Poon WS. Aneurysmal subarachnoid haemorrhage. Surg Pract. 2008;12:51-55.
3. Wong GK, Boet R, Ng SC, Chan M, Gin T, Zee B, et al. Ultra-early (within 24 hours) aneurysm treatment after subarachnoid hemorrhage. World Neurosurg. 2012;77:311-315. doi: 10.1016/j.wneu.2011.09.025.
4. Knuckey NW, Fox RA, Surveyor I, Stokes BA. Early cerebral blood flow and computerized tomography in predicting ischemia after cerebral aneurysm rupture. J Neurosurg. 1985;62:850-855. doi: 10.3171/jns.1985.62.6.0850.
5. Abla AA, Wilson DA, Williamson RW, Nakaji P, McDougall CG, Zabramski JM, et al. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial. J Neurosurg. 2014;120:391-397. doi: 10.3171/2013.10.JNS13419.
6. Chen S, Feng H, Sherchan P, Klebe D, Zhao G, Sun X, et al. Controversies and evolving new mechanisms in subarachnoid hemorrhage. Prog Neurobiol. 2014;115:64-91. doi: 10.1016/j.pneurobio.2013.09.002.
7. STASH Trial. SimvaSTatin in Aneurysmal Subarachnoid Haemorrhage - a multicentre randomised controlled clinical phase III study protocol. http://www.stashtrial.com/Stash-pdf/2011/STASH%20study%20protocol. pdf. Accessed February 17, 2014.
8. Endres M. Statins and stroke. J Cereb Blood Flow Metab. 2005;25:1093-1110. doi: 10.1038/sj.jcbfm.9600116.
9. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, et al. Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol. 2003;53:743-751. doi: 10.1002/ana.10555.
10. Chen J, Cui X, Zacharek A, Chopp M. Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med. 2009;13:1348-1357. doi: 10.1111/j.1582-4934.2008.00380.x.
11. Wong GK, Poon WS. The biochemical basis of hydroxymethylglutaryl-CoA reductase inhibitors as neuroprotective agents in aneurysmal subarachnoid hemorrhage. Pharmaceuticals. 2010;3:3186-3199.
12. Sabri M, Ai J, Marsden PA, Macdonald RL. Simvastatin re-couples dysfunctional endothelial nitric oxide synthase in experimental subarachnoid hemorrhage. PLoS One. 2011;6:e17062. doi: 10.1371/journal. pone.0017062.
13. McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke. 2002;33:2950-2956.
14. Lynch JR, Wang H, McGirt MJ, Floyd J, Friedman AH, Coon AL, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005;36:2024-2026. doi: 10.1161/01.STR.0000177879.11607.10.
15. Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627-1632. doi: 10.1161/01.STR.0000176743.67564.5d.
16. Chou SH, Smith EE, Badjatia N, Nogueira RG, Sims JR II, Ogilvy CS, et al. A randomized, double-blind, placebo-controlled pilot study of simvastatin in aneurysmal subarachnoid hemorrhage. Stroke. 2008;39:2891-2893. doi: 10.1161/STROKEAHA.107.505875.
17. Kirkpatrick PJ, Turner CL, Smith C, Hutchinson PJ, Murray GD; STASH Collaborators. Simvastatin in aneurysmal subarachnoid haemorrhage (STASH): a multicentre randomised phase 3 trial. Lancet Neurol. 2014;13:666-675. doi: 10.1016/S1474-4422(14)70084-5.
18. Wong GK, Liang M, Tan H, Lee MW, Po YC, Chan KY, et al. High-dose simvastatin for aneurysmal subarachnoid hemorrhage: a multicenter, randomized, controlled, double-blind clinical trial protocol. Neurosurgery. 2013;72:840-844. doi: 10.1227/NEU.0b013e31828ab413.
19. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group. Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12064 survivors of myocardial infarction: a double-blind randomized trial. Lancet. 2010;376:1658-1669.
20. Wong GK, Chan TV, Poon WS, Boet R, Gin T. Intravenous magnesium sulphate to improve outcome after aneurysmal subarachnoid hemorrhage. J Neurosurg Anaesthes. 2006;18:142-148.
21. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al; IMASH Investigators. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebocontrolled, multicenter phase III trial. Stroke. 2010;41:921-926. doi: 10.1161/STROKEAHA.109.571125.
22. Wong GK, Lam S, Ngai K, Wong A, Mok V, Poon WS; Cognitive Dysfunction After Aneurysmal Subarachnoid Haemorrhage Investigators. Evaluation of cognitive impairment by the Montreal cognitive assessment in patients with aneurysmal subarachnoid haemorrhage: prevalence, risk factors and correlations with 3 month outcomes. J Neurol Neurosurg Psychiatry. 2012;83:1112-1117. doi: 10.1136/jnnp-2012-302217.
23. Weis M, Heeschen C, Glassford AJ, Cooke JP. Statins have biphasic effects on angiogenesis. Circulation. 2002;105:739-745.
24. Urbich C, Dernbach E, Zeiher AM, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res. 2002;90:737-744.
25. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients: post-hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial. Stroke. 2010;41:1841-1844.
26. Uekawa K, Hasegawa Y, Ma M, Nakagawa T, Katayama T, Sueta D, et al. Rosuvastatin ameliorates early brain injury after subarachnoid hemorrhage via suppression of superoxide formation and nuclear factor-kappa B activation in rats. J Stroke Cerebrovasc Dis. 2014;23:1429-1439. doi: 10.1016/j.jstrokecerebrovasdis.2013.12.004.
27. Wong GK, Lam SW, Ngai K, Wong A, Siu D, Poon WS, et al; Cognitive Dysfunction After Aneurysmal Subarachnoid Hemorrhage Investigators. Cognitive domain deficits in patients with aneurysmal subarachnoid haemorrhage at 1 year. J Neurol Neurosurg Psychiatry. 2013;84:1054-1058. doi: 10.1136/jnnp-2012-304517.
28. Wong GK, Wong R, Mok VC, Fan DS, Leung G, Wong A, et al. Clinical study on cognitive dysfunction after spontaneous subarachnoid haemorrhage: patient profiles and relationship to cholinergic dysfunction. Acta Neurochir. 2009;151:1601-1607.
29. Wong GK, Lam SW, Wong A, Lai M, Siu D, Poon WS, et al. MoCAassessed cognitive function and excellent outcome after aneurysmal subarachnoid hemorrhage at 1 year. Eur J Neurol. 2014;21:725-730. doi: 10.1111/ene.12363.
30. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al; STICH Investigators. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet. 2005;365:387-397. doi: 10.1016/S0140-6736(05)17826-X.